Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for non-exclusive discount agreements for the drug Pazopanib under an Open-House model issued by AOK PLUS, located in Erfurt, Germany. The contract will be valid until January 31, 2029, with initial applications due by January 5, 2027.
Scope Of Work: The tender involves establishing non-exclusive discount agreements for the drug Pazopanib (ATC Code: L01EX03) in accordance with § 130a Abs. 8 SGB V. The agreements will be open to all interested pharmaceutical companies during the participation period, without individual contract negotiations or exclusivity. The quantities to be purchased are unpredictable, dependent on demand and other factors. Interested companies must download participation documents from the German Procurement Portal (DTVP) after applying for access. Confidentiality of the agreement terms is mandatory.
Qualification Criterion: Pharmaceutical companies interested in participating must fulfill specified participation requirements and accept the terms outlined in the participation documents. They must submit necessary documentation as detailed in the DTVP portal. The tender does not guarantee minimum purchase quantities, and all submitted materials must be destroyed if participation is declined. The submission of participation applications begins on January 5, 2027, with further deadlines available in the project documents.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |